vTv Therapeutics Inc(NASDAQ:VTVT) 
vTv Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers, develops, and sells orally administered small molecule drug candidates to fill unmet medical needs. The company is developing TTP399, an orally administered, small molecule, liver-selective glucokinase activator for the tr...
Website: http://www.vtvtherapeutics.com
Founded: 2015
Full Time Employees: 26
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 16.57
H 16.70
L 16.15
C 16.26
V 6,375
10EMA 16.26
20EMA 16.26
60EMA 16.26
120EMA 16.26
250EMA 16.26